Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Return on Capital Employed (2018 - 2025)

Catheter Precision has reported Return on Capital Employed over the past 8 years, most recently at 126.16% for Q4 2025.

  • Quarterly Return on Capital Employed fell 8123.0% to 126.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 126.16% through Dec 2025, down 8123.0% year-over-year, with the annual reading at 118.06% for FY2025, 7646.0% down from the prior year.
  • Return on Capital Employed was 126.16% for Q4 2025 at Catheter Precision, down from 70.98% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 44.75% in Q2 2024 and troughed at 311.64% in Q1 2023.
  • The 5-year median for Return on Capital Employed is 136.74% (2021), against an average of 143.15%.
  • Year-over-year, Return on Capital Employed plummeted -15943bps in 2023 and then surged 25891bps in 2024.
  • A 5-year view of Return on Capital Employed shows it stood at 159.44% in 2021, then tumbled by -77bps to 281.5% in 2022, then increased by 5bps to 266.33% in 2023, then skyrocketed by 83bps to 44.92% in 2024, then crashed by -181bps to 126.16% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Return on Capital Employed are 126.16% (Q4 2025), 70.98% (Q3 2025), and 68.99% (Q2 2025).